A Graphene‐Based Flexible Device as a Specific Far‐Infrared Emitter for Noninvasive Tumor Therapy

Abstract Noninvasive treatments are emerging as a promising strategy not only due to their non‐invasive nature, but also due to their additive effects to traditional radiotherapy and chemotherapy. Herein, specific far‐infrared rays generated from single‐layer, graphene‐based devices are applied to tumors as a novel noninvasive therapeutic strategy. In MDA‐MB‐231 breast cancer cell xenograft and metastasis models, irradiation generated from this flexible device reduces the rate of tumor growth and the number of metastatic nodules per lung by 42% and 55%, respectively. This result might be induced by the similarity between the emission spectra of the device and the absorption spectra of the living tissue. With its high energy conversion and safety, the graphene‐based device can serve as an adjuvant therapeutic instrument for combined tumor treatment.